Tiny Sienna is calling in Cowen as shares continue to languish long after a severe trial setback
With its cash reserves shrinking and its stock stuck in penny stock territory, tiny Sienna Biopharmaceuticals is bringing in Cowen to explore what kind of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.